Basal cytokeratins and their relationship to the cellular origin and functional classification of breast cancer

Breast Cancer Research

Volumn 7, Issue 4, 2005, Pages 143-148

  Gusterson, Barry A ^a   Ross, Douglas T ^b   Heath, Victoria J ^a   Stein, Torsten ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b Applied Genomics Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; COMPLEMENTARY DNA; CYTOKERATIN; CYTOKERATIN 17; CYTOKERATIN 5; MATRIX METALLOPROTEINASE 14; RNA;

BASAL CELL; BASAL CELL CARCINOMA; BREAST CANCER; CANCER CLASSIFICATION; CARCINOGENESIS; CELL LINEAGE; CELL TYPE; DNA MICROARRAY; GENE EXPRESSION; HUMAN; HYPOTHESIS; MEDICAL TECHNOLOGY; NOMENCLATURE; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW;

BREAST; BREAST NEOPLASMS; CARCINOMA, BASAL CELL; EPITHELIAL CELLS; FEMALE; GENE EXPRESSION PROFILING; HUMANS; IMMUNOHISTOCHEMISTRY; KERATINS; PROGNOSIS;

EID: 21044455192     PISSN: 14655411     EISSN: None     Source Type: Journal    
DOI: 10.1186/bcr1041     Document Type: Review

References (54)

1. Behbod F, Rosen JM: Will cancer stem cells provide new therapeutic targets? Carcinogenesis 2004, 26:703-711.
2. Wilson CA, Dering J: Recent translational research: microarray expression profiling of breast cancer - beyond classification and prognostic markers? Breast Cancer Res 2004, 6:192-200.
3. Anbazhagan R, Osin PP, Bartkova J, Nathan B, Lane B, Gusterson BA: The development of epithelial phenotypes in the human fetal and infant breast. J Pathol 1998, 184:197-206.
4. Gusterson BA, Warburton MJ, Mitchell D, Ellison M, Neville AM, Rudland PS: Distribution of myoepithelial cells and basement membrane proteins in the normal breast and in benign and malignant breast disease. Cancer Res 1982, 42:4763-4770.
5. Gusterson BA, Monaghan P, Mahendran R, Ellis J, O'Hare MJ: Identification of myoepithelial cells in human and rat breasts by anti-common acute lymphoblastic leukaemia antigen antibody A12. J Natl Cancer Inst 1986, 77:343-349.
6. Moll R, Franke WW, Schiller DL: The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells. Cell 1982, 31:11-24.
7. Moll R, Krepler R, Frank WW: Complex cytokeratin polypeptide patterns observed in certain human carcinomas. Differentiation 1983, 23:256-269.
8. Nagle RB, Bocker W, Davis JR, Heid HW, Kaufmann M, Lucas DO, Jarasch ED: Characterization of breast carcinomas by two monoclonal antibodies distinguishing myoepithelial from luminal epithelial cells. J Histochem Cytochem 1986, 34:869-881.
9. Ben-Ze'ev A: Cell density and cell shape-related regulation of vimentin and cytokeratin synthesis. Exp Cell Res 1985, 157: 520-532.
10. Su L, Morgan PR, Lane EB: Expression of cytokeratin messenger RNA versus protein in the normal mammary gland and in breast cancer. Hum Pathol 1996, 27:800-806.
11. Wetzels RHW, Kuijpers HJH, Lane EB, Leigh IM, Troyanovsky SM, Holland R, van Haelst UJGM, Ramaekers PCS: Basal cell specific and hyperproliferation-related keratins in human breast cancer. Am J Pathol 1991, 138:751-763.
12. Malzahn K, Mitze M, Thoenes M, Moll R: Biological and prognostic significance of stratified epithelial cytokeratins in infiltrating ductal breast carcinomas. Virchows Arch 1998, 433: 119-129.
13. Otterbach F, Bànkfalvi À, Bergner S, Decker T, Krech R, Boecker W: Cytokeratin 5/6 immunohistochemistry assists the differential diagnosis of atypical proliferations of the breast. Histopathology 2000, 37:232-240.
14. Boecker W, Buerger H: Evidence of progenitor cells of glandular and myoepithelial cell lineages in the human adult female breast epithelium: a new progenitor (adult stem) cell concept. Cell Prolif 2003, 36:73-84.
15. Smith GH, Mehrel T, Roop DR: Differential keratin gene expression in developing, differentiating, preneoplastic, and neoplastic mouse mammary epithelium. Cell Growth Differ 1990, 1:161-170.
16. Page MJ, Amess B, Townsend RR, Parekh R, Herath A, Brusten L, Zvelebil MJ, Stein RC, Waterfield MD, Davies SC, et al.: Proteomic definition of normal human luminal and myoepithelial breast cells purified from reduction mammoplasties. Proc Natl Acad Sci USA 1999, 96:12589-12594.
17. Wellings SR: A hypothesis of the origin of human breast cancer from the terminal ductal lobular unit. Pathol Res Pract 1980, 166:515-535.
18. Jensen HM, Rice JR, Wellings SR: Preneoplastic lesions in the human breast. Science 1976, 191:295-297.
19. Wellings SR, Jensen HM, Marcum RG: An atlas of subgross pathology of the human breast with special reference to possible precancerous lesions. J Natl Cancer Inst 1975, 55:231-273.
20. Osin P, Shipley J, Lu YJ, Crook T, Gusterson BA: Experimental pathology and breast cancer genetics: new technologies. Recent Results Cancer Res 1998, 152:35-48.
21. Simpson PT, Reis-Filho JS, Gale T, Lakhani SR: Molecular evolution of breast cancer. J Pathol 2005, 205:248-254.
22. Diallo R, Schaefer K-L, Poremba C, Shivazi N, Willman V, Buerger H, Dockhorn-Dworniczak B, Boecker W: Monoclonality in normal epithelium and in hyperplastic and neoplastic lesions of the breast. J Pathol 2001, 193:27-32.
23. O'Hare MJ, Ormerod MG, Monaghan P, Lane EB, Gusterson BA: Characterization in vitro of luminal and myoepithelial cells isolated from the human mammary gland by cell sorting. Differentiation 1991, 46:209-221.
24. Péchoux C, Gudjonsson T, Rønnov-Jessen L, Bissell MJ, Petersen OW: Human mammary luminal epithelial cells contain progenitors to myoepithelial cells. Dev Biol 1999, 206:88-99.
25. Jarasch ED, Nagle RB, Kaufmann M, Maurer C, Bocker WJ: Differential diagnosis of benign epithelial proliferations and carcinomas of the breast using antibodies to cytokeratins. Hum Pathol 1988, 19:276-289.
26. Böcker W, Moll R, Poremba C, Holland R, van Diest PJ, Dervan P, Bürger J, Wai D, Diallo RI, Brandt B, et al.: Common adult stem cells in the human breast give rise to glandular and myoepithelial cell lineages: a new cell biological concept. Lab Invest 2002, 82:737-745.
27. Alvi AJ, Clayton H, Joshi C, Enver T, Ashworth A, Vivanco M dM, Dale TC, Smalley MJ: Functional and molecular characerisation of mammary side population cells. Breast Cancer Res 2002, 5: R1-R8.
28. Clayton H, Titley I, Vivanco M: Growth and differentiation of progenitor/stem cells derived from the human mammary gland. Exp Cell Res 2004, 297:444-460.
29. pos cells in the mouse mammary gland represent an enriched progenitor cell population. Dev Biol 2002, 245:42-56.
30. Clarke RB, Spence K, Anderson E, Howell A, Okano H, Potten CS: A putative breast stem cell population is enriched for steroid receptor-positive cells. Dev Biol 2005, 277:443-456.
31. Petersen OW, Gudjonsson T, Villadsen R, Bissell MJ, Rønnov-Jessen L: Epithelial progenitor cell lines as models of normal breast morphogenesis and neoplasia. Cell Prolif 2003, 36:33-44.
32. Dontu G, El-Ashry D, Wicha MS: Breast cancer, stem/progenitor cells and the estrogen receptor. Trends Endocrinol Metab 2004, 15:193-197.
33. Taylor-Papadimitrou J, Stampfer M, Bartek J, Lewis A, Boshell M, Lane EB, Leigh IM: Keratin expression in human mammary epithelial cells cultured from normal and malignant tissue: relation of in vivo phenotypes and influence of medium. J Cell Sci 1989, 94:403-413.
34. Perou CM, Sorlie T, Eisen MB, van de Rijn M, Jeffrey SS, Rees CA, Pollack JR, Ross DT, Johnsen H, Akslen LA, et al.: Molecular portraits of human breast tumours. Nature 2000, 406:747-752.
35. Sorlie T, Perou CM, Tibshirani R, Aas T, Geisler S, Johnsen H, Hastie T, Eisen MB, van de Rijn M, Jeffrey SS, et al.: Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci USA 2001, 98:10869-10874.
36. Sorlie T, Tibshirani R, Parker J, Hastie T, Marron JS, Nobel A, Deng S, Johnsen H, Pesich R, Geisler S, et al.: Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc Natl Acad Sci USA 2003, 100:8418-8423.
37. Sotiriou C, Neo SY, McShane LM, Korn EL, Long PM, Jazaeri A, Martiat P, Fox SB, Harris AL, Liu ET: Breast cancer classification and prognosis based on gene expression profiles from a population-based study. Proc Natl Acad Sci USA 2003, 100: 10393-10398.
38. Zhao H, Langerod A, Ji Y, Nowels KW, Nesland JM, Tibshirani R, Bukholm IK, Karesen R, Botstein D, Borresen-Dale AL, et al.: Different gene expression patterns in invasive lobular and ductal carcinomas of the breast. Mol Biol Cell 2004, 15:2523-2536.
39. Ross DT, Perou CM: A comparison of gene expression signatures from breast tumors and breast tissue derived cell lines. Dis Markers 2001, 17:99-109.
40. Foulkes WD, Stefansson IM, Chappuis PO, Bégin LR, Goffin JR, Wong N, Trudel M, Akslen LA: Germline BRCA1 mutations and a basal epithelial phenotype in breast cancer. J Natl Cancer Inst 2003, 95:1482-1485.
41. Foulkes WD: BRCA1 functions as a breast stem cell regulator. J Med Genet 2004, 41:1-5.
42. Jones C, Nonni AV, Fulford L, Merrett S, Chaggar R, Eusebi V, Lakhani SR: CGH analysis of ductal carcinoma of the breast with basaloid/myoepithelial cell differentiation. Br J Cancer 2001, 85:422-427.
43. Korsching E, Packeisen J, Agelopoulos K, Eisenacher M, Voss R, Isola J, van Diest PJ, Brandt B, Boecker W, Buerger H: Cytogenetic alterations and cytokeratin expression patterns in breast cancer: integrating a new model of breast differentiation into cytogenetic pathways of breast carcinogenesis. Lab Invest 2002, 82:1525-1533.
44. Jones C, Ford E, Gillett C, Ryder K, Merrett S, Reis-Filho JS, Fulford LG, Hanby A, Lakhani SR: Molecular cytogenetic identification of subgroups of grade III invasive ductal breast carcinomas with different clinical outcomes. Clin Cancer Res. 2004, 10:5988-5997.
45. Reis-Filho JS, Milanezi F, Paredes J, Silva P, Pereira EM, Maeda SA, de Carvalho LV, Schmitt FC: Novel and classic myoepithelial/stem cell markers in metaplastic carcinomas of the breast. Appl Immunohistochem Mol Morphol 2003, 11:1-8.
46. Chung CH, Bernard PS, Perou CM: Molecular portraits and the family tree of cancer. Nat Genet 2002, Suppl:533-540.
47. Chung CH, Parker JS, Karaca G, Wu J, Funkhouser WK, Moore D, Butterfoss D, Xiang D, Zanation A, Yin X, et al.: Molecular classification of head and neck squamous cell carcinomas using patterns of gene expression. Cancer Cell 2004, 5:489-500.
48. Nagle RB: Intermediate filaments: efficacy in surgical pathologic diagnosis. Am J Clin Pathol 1989, 91:14-18.
49. Dairkee SH, Mayall BH, Smith HS, Hackett AJ: Monoclonal marker that predicts early recurrence of breast cancer. Lancet 1987, 11:514.
50. Abd El-Rehim DM, Pinder SE, Paish CE, Bell J, Blamey RW, Robertson JFR, Nicholson RI, Ellis IO: Expression of luminal and basal cytokeratins in human breast carcinoma. J Pathol 2004, 203:661-671.
51. Van de Rijn M, Perou CM, Tibshirani R, Haas P, Kallioniemi O, Kononen J, Torhorst J, Sauter G, Zuber M, Köchli OR, et al.: Expression of cytokeratins 17 and 5 identifies a group of breast carcinomas with poor clinical outcome. Am J Pathol 2002, 161:1991-1996.
52. Tot T: The cytokeratin profile of medullary carcinoma of the breast. Histopathology 2000, 37:175-181.
53. Nielsen TO, Hsu FD, Jensen K, Cheang M, Karaca G, Hu Z, Hernandex-Boussard T, Livasy C, Cowan D, Dressler L, et al.: Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma. Clin Cancer Res 2004, 10:5367-5374.
54. Troester MA, Hoadley KA, Sorlie T, Herbert BS, Borresen-Dale AL, Lonning PE, Shay JW, Kaufmann WK, Perou CM: Cell-type-specific responses to chemotherapeutics in breast cancer. Cancer Res 2004, 64:4218-4226.